Aeglea BioTherapeutics is Drug Discovery in United States that focus on Aeglea BioTherapeutics Inc business. Founded in 2013. They cover business area such as Aeglea BioTherapeutics Inc, innovative human enzyme therapeutic, patient, rare genetic disease, cancer, pegzilarginase, an early clinical development stage.
2013
( 11 years old in 2024 )
Aeglea BioTherapeutics Inc
-
901 South MoPac Expressway
Barton Oaks Plaza One, Suite 250
Austin, TX 78746
United States
Private
Aeglea BioTherapeutics Incinnovative human enzyme therapeuticpatientrare genetic diseasecancerpegzilarginasean early clinical development stage
* We use standard office opening hours in near Aeglea BioTherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aeglea BioTherapeutics is Drug Discovery business from United States that founded in 2013 (11 years old in 2024), Aeglea BioTherapeutics business is focusing on Aeglea BioTherapeutics Inc.
Aeglea BioTherapeutics headquarter office and corporate office address is located in 901 South MoPac Expressway Barton Oaks Plaza One, Suite 250 Austin, TX 78746 United States.
Aeglea BioTherapeutics was founded in United States.
In 2024, Aeglea BioTherapeutics is currently focus on Aeglea BioTherapeutics Inc sector.
Above is snippet of Google Trends for "Aeglea BioTherapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aeglea BioTherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
